Mamintas, Baby Boy .

HRN: 25-50-01  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/12/2024
AMPICILLIN 1GM (VIAL)
07/12/2024
07/19/2024
IV
170mg
Q12h
PSNB
Waiting Final Action 
07/12/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
07/12/2024
07/19/2024
IV
17
Q24h
PSNB
Waiting Final Action 
07/14/2024
CEFOTAXIME 500MG (VIAL)
07/14/2024
07/21/2024
INTRAVENOUS
165 Mg IVTT
Every 12 Hours
Neonatal Pneumonia
Waiting Final Action 
07/20/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/20/2024
07/27/2024
IV
330mg
Q 8 Hours
T/C Neonatal Sepsis
Waiting Final Action 
07/20/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/20/2024
07/27/2024
IV
40 Mg
Q 24
T/C Neonatal Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: